What is keeping Adar Poonawalla busy these days?

Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more

Adar Poonawalla (Photo: Kamlesh Pednekar)

1 min read Last Updated : Aug 04 2022 | 7:00 AM IST

Innovation has also been the key to the success of Adar Poonawala. He has taken Indian vaccines to the US and European markets. In an interview with Business Standard’s Sohini Das, Poonawalla tells about his plans, which include mass production of malaria vaccines, nasal flu vaccine and exploring a vaccine for monkeypox too. Let us listen in to the interview in this podcast.

More From This Section

We've demonstrated our quality & capability to enter US, Europe: SII CEO

Real estate demand from industries is seeing a steep rise: Arun Nanda

We will grow VNB in line with industry after FY23: ICICI Pru Life MD & CEO

We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD

Topics :Serum Institute of India Serum Institute Vaccine Malaria vaccine medical technology

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 04 2022 | 7:00 AM IST